Identification of Genomic Binding Sites for Candida glabrata Pdr1 Transcription Factor in Wild-Type and ρ 0 Cells
Open accessAbstract
The fungal pathogen Candida glabrata is an emerging cause of candidiasis in part owing to its robust ability to acquire tolerance to the major clinical antifungal drug fluconazole. Similar to the related species Candida albicans , C. glabrata most typically gains azole tolerance via transcriptional induction of a suite of resistance genes, including a locus encoding an ABCG-type ATP-binding cassette (ABC) transporter that is referred to as CDR1 in Candida species. In C. glabrata , CDR1 expression is controlled primarily by the activity of a transcriptional activator protein called Pdr1. Strains exhibiting reduced azole susceptibility often contain substitution mutations in PDR1 that in turn lead to elevated mRNA levels of target genes with associated azole resistance. Pdr1 activity is also induced upon loss of the mitochondrial genome status and upon challenge by azole drugs. While extensive analyses of the transcriptional effects of Pdr1 have identified a number of genes that are regulated by this factor, we cannot yet separate direct from indirect target genes. Here we used chromatin immunoprecipitation (ChIP) coupled with high-throughput sequencing (ChIP-seq) to identify the promoters and associated genes directly regulated by Pdr1. These genes include many that are shared with the yeast Saccharomyces cerevisiae but others that are unique to C. glabrata , including the ABC transporter-encoding locus YBT1 , genes involved in DNA repair, and several others. These data provide the outline for understanding the primary response genes involved in production of Pdr1-dependent azole resistance in C. glabrata .
AI snapshot
Written from the paper’s full text.
TL;DR
ChIP-seq was used to identify promoters directly bound by *Candida glabrata* Pdr1 in wild-type (ρ+) and mitochondrial-genome-loss (ρ0) cells, yielding a minimal set of 25 Pdr1 target genes. The direct Pdr1 regulon overlaps with the *Saccharomyces cerevisiae* Pdr network but includes *C. glabrata*-specific targets such as *YBT1*, *QDR2*, and DNA repair genes.
Key findings
- Anti-Pdr1 ChIP-seq identified 25 genes with reproducible promoter enrichment in ρ0 versus ρ+ cells; 16 of 25 were also enriched with anti-TAP Pdr1.
- The target set includes shared Pdr-regulon genes such as *CDR1*, *PDH1*, *SNQ2*, *YOR1*, *PDR16*, *RTA1*, *RSB1*, *IPT1*, and *RPN4*, plus *C. glabrata*-specific or newly implicated genes including *YBT1*, *QDR2*, *REV1*, *MEC3*, *PUP1*, *ATF2*, and *NCE103*.
- ρ0 induction values from the accompanying dataset ranged widely, e.g., *PUP1* 57×, *YOR1* 22×, *PDH1* 18×, *CAGL0A01650g* 12×, *RTA1* 12×, *ATF2* 10×, *MEC3* 9×, and *CDR1* 4×.
- MEME analysis found a promoter motif closely related to the *S. cerevisiae* pleiotropic drug resistance response element (PDRE), supporting a conserved PDRE-like element in *C. glabrata*.
Methods
- Isogenic *C. glabrata* ATCC 2001 strains were used, including a *pdr1Δ*::*natMX* strain and a strain expressing TAP-tagged Pdr1 as the sole Pdr1 source; ρ0 derivatives were generated by ethidium bromide treatment and confirmed by DAPI staining and inability to grow on nonfermentable carbon source.
- ChIP-seq was performed with anti-Pdr1 and anti-TAP antibodies in ρ+ and ρ0 cells, with controls including *pdr1Δ* chromatin and no-primary-antibody reactions; libraries were sequenced on an Illumina HiSeq 2500 and reads aligned to the *C. glabrata* genome ASM254v2 with Bowtie 2.
- Peaks were assessed with spp and ccQualityControl, annotated with ChipPeakAnno and annotatePeaks.pl, and motif discovery used MEME; selected promoters (*CDR1*, *YBT1*, *MEC3*, *PUP1*) were validated by standard ChIP-PCR.
Limitations
- Stated: *PDR1* itself was not included in the 25-gene list because anti-Pdr1 ChIP-seq did not reproduce the anti-TAP signal at its promoter; the authors note possible epitope occlusion and state that further analyses are required to confirm Pdr1 binding to its own promoter.
- Stated: two binding sites between divergently transcribed gene pairs were identified, but because those genes were not reported as ρ0-induced, the significance of their Pdr1 association remains to be determined.
- Stated/evident: the authors emphasize that PDRE function requires direct functional validation, since sequence-based predictions can be misleading; most target promoters were not functionally tested, and the 25-gene set is described as a minimal list from a laboratory strain rather than clinical isolates.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
0 of 47 cited sources checked · 0 supported · 0 flagged
- Findingown data
The anti-TAP Western blotting detected a single species consistent with the predicted approximately 150-kDa size of the full-length TAP-Pdr1 fusion protein.
“The anti-TAP Western blotting also detected a single species of protein immunoreactive with this antibody that was consistent with the predicted ∼150-kDa size of the full-length TAP-Pdr1 fusion protein.”
Quote in the paperSubstantial claim - Findingown data
Two other binding sites placed between divergently transcribed genes were identified, located between CAGL0B02101/CAGL0B02079 and CAGL0C02937g/CAGL0C02893g.
“Two other binding sites placed between divergently transcribed genes were also identified. These elements were located between the CAGL0B02101/CAGL0B02079 and CAGL0C02937g/CAGL0C02893g genes.”
Quote in the paperNot a substantial claim - Findingown data
The most abundant target gene directs production of membrane transporter proteins.
“The most abundant target gene directs production of membrane transporter proteins.”
Quote in the paperNot a substantial claim - Findingown data
Our analysis identified a set of 25 genes showing reproducible enrichment using the anti-Pdr1 antiserum in rho0 cells compared to rho+ cells.
“Our analysis identified a set of 25 genes showing reproducible enrichment using the anti-Pdr1 antiserum in ρ0 cells compared to results in ρ+ cells.”
Quote in the paperSubstantial claim - Findingown data
ChIP analysis showed increased representation of the CDR1, YBT1, MEC3, and PUP1 promoters in a ChIP sample from ρ0 cells compared to that from ρ+ cells.
“As predicted by the ChIP-seq analysis, increased representation of all of these promoters is seen in a ChIP sample from ρ0 cells compared to that from ρ+ cells.”
Quote in the paperSubstantial claim- Rests on an assumption: The anti-Pdr1 antiserum specifically immunoprecipitates Pdr1 in the ChIP assays.
- Findingown data
Sixteen of twenty-five genes were similarly enriched when using the anti-TAP antibody in isogenic rho0 and rho+ cells expressing TAP-Pdr1.
“Sixteen of twenty-five genes were similarly enriched when using the anti-TAP antibody in the isogenic ρ0 and ρ+ cells expressing the TAP-Pdr1 fusion protein.”
Quote in the paperSubstantial claim - Findingown data
The anti-Pdr1 antiserum detects a single immunoreactive species in wild-type cells closely matching the predicted 126-kDa size of full-length Pdr1.
“First, a single immunoreactive species was detected in wild-type cells closely matching the predicted 126 -kDa size of full-length Pdr1.”
Quote in the paperSubstantial claim - Findingown data
YBT1 is an ABC transporter controlled via the Pdr regulon in C. glabrata.
“*YBT1* is an interesting new ABC transporter form controlled via the Pdr regulon in *C. glabrata*.”
Quote in the paperSubstantial claim - Findingnone given
A GTPase-activating protein called Bag7 is also a Pdr1 transcriptional target.
“A GTPase-activating protein called Bag7 is also a Pdr1 transcriptional target.”
Quote in the paperNot a substantial claim - Findingown data
REV1 exhibits Pdr1 binding to its promoter.
“Another DNA repair enzyme was encoded by a gene exhibiting Pdr1 binding to its promoter. This is the *REV1* locus”
Quote in the paperNot a substantial claim - Findingcitation
Several other membrane-bound or integral membrane proteins are regulated by Pdr1.
“Several other membrane-bound or integral membrane proteins are regulated by Pdr1.”
Quote in the paperNot a substantial claim - Findingnone given
Two 7-transmembrane proteins, encoded by RSB1 and RTA1, are highly responsive to increased Pdr1 transcriptional activation.
“Two 7-transmembrane proteins, encoded by *RSB1* and *RTA1*, are highly responsive to increased Pdr1 transcriptional activation.”
Quote in the paperNot a substantial claim - Findingown data
Genes encoding enzymes with functions associated with the mitochondria are also induced in cells lacking this organellar genome.
“Genes encoding enzymes with functions associated with the mitochondria are also induced in cells lacking this organellar genome.”
Quote in the paperSubstantial claim - Findingown data
Several genes encoding enzymes generally involved in oxidation/reduction reactions possess significant Pdr1 binding activity on their promoters.
“Several genes encoding enzymes generally involved in oxidation/reduction reactions possess significant Pdr1 binding activity on their promoters.”
Quote in the paperSubstantial claim - Findingown data
Two genes encoding membrane biosynthetic enzymes, IPT1 and PDR16, contain significant Pdr1 binding in their promoter regions.
“Two genes encoding membrane biosynthetic enzymes were found to contain significant Pdr1 binding in their promoter regions. These are the mannosyl-(diinositol phosphoryl)-ceramide synthase-encoding gene *IPT1* and the phosphatidylinositol transferase protein-encoding gene *PDR16*.”
Quote in the paperSubstantial claim - Findingown data
The second-largest class of Pdr1 targets identified in C. glabrata are genes involved in metabolism at some level.
“The second-largest class of Pdr1 targets identified in *C. glabrata* are genes involved in metabolism at some level.”
Quote in the paperNot a substantial claim - Findingown data
CAGL0A01650g is a unique member of the C. glabrata Pdr regulon that has no apparent homologue in S. cerevisiae or in any other fungus.
“Our analysis also identified a unique member of the *C. glabrata* Pdr regulon that has no apparent homologue in *S. cerevisiae* or in any other fungus (our unpublished data).”
Quote in the paperNot a substantial claim - Findingown data
Pdr1 target genes include two known transcriptional regulators, RPN4 and HAP1.
“Pdr1 target genes were also found to include two known transcriptional regulators: *RPN4* and *HAP1.”
Quote in the paperSubstantial claim - Premisecitation
Gain-of-function mutations in PDR1 are a primary means by which Candida glabrata acquires azole resistance.
“The primary means are provided by gain-of-function (GOF) mutations in the gene encoding the key transcription factor Pdr1 ([6](#B6), [7](#B7)).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [6] Vermitsky JP, Edlind TD. 2004. Azole resistance in Candida glabrata: coordinate upregulation of multidrug transporters and evidence for a Pdr1-like transcription factor. Antimicrob. Agents Chemother. 48:3773–3781. 10.1128/AAC.48.10.3773-3781.2004. [[DOI](https://doi.org/10.1128/AAC.48.10.3773-3781.2004)] [[PMC free article](/articles/PMC521908/)] [[PubMed](https://pubmed.ncbi.nlm.nih.gov/15388433/)] [[Google Scholar](https://scholar.google.com/scholar_lookup?journal=Antimicrob.%20Agents%20Chemother.&title=Azole%20resistance%20in%20Candida%20glabrata:%20coordinate%20upregulation%20of%20multidru source
Not checked in the free run.
- cites [7] Tsai HF, Krol AA, Sarti KE, Bennett JE. 2006. Candida glabrata PDR1, a transcriptional regulator of a pleiotropic drug resistance network, mediates azole resistance in clinical isolates and petite mutants. Antimicrob. Agents Chemother. 50:1384–1392. 10.1128/AAC.50.4.1384-1392.2006. [[DOI](https://doi.org/10.1128/AAC.50.4.1384-1392.2006)] [[PMC free article](/articles/PMC1426987/)] [[PubMed](https://pubmed.ncbi.nlm.nih.gov/16569856/)] [[Google Scholar](https://scholar.google.com/scholar_lookup?journal=Antimicrob.%20Agents%20Chemother.&title=Candida%20glabrata%20PDR1,%20a%20transcriptional%20reg source
Not checked in the free run.
- Interpretationreasoning
The detected element is likely to be the authentic PDRE used in C. glabrata.
“This extensive conservation argues that this element is likely to be the authentic PDRE used in *C. glabrata*.”
Quote in the paperSubstantial claim - Interpretationown data
This analysis provides the first determination of the suite of Pdr1-regulated genes that are bound by Pdr1 in vivo and likely to serve as primary response genes when this factor is activated.
“This analysis provides the first determination of the suite of Pdr1-regulated genes that are bound by Pdr1 *in vivo* and likely to serve as primary response genes when this factor is activated.”
Quote in the paperSubstantial claim - Interpretationown data
The membrane transporter target class in C. glabrata is similar to the situation in S. cerevisiae.
“This is similar to the situation in *S. cerevisiae*, although there are two unique *C. glabrata* targets, *YBT1* and *QDR2.”
Quote in the paperNot a substantial claim - Interpretationown data
The 25 genes considered represent a minimal list of Pdr1 target genes.
“The 25 genes considered here represent what we could term a minimal list of Pdr1 target genes.”
Quote in the paperNot a substantial claim - Interpretationnone given
There are two unique C. glabrata targets, YBT1 and QDR2.
“although there are two unique *C. glabrata* targets, *YBT1* and *QDR2.”
Quote in the paperNot a substantial claim - Premisecitation
In CDR1, truncation mutant forms of the promoter fused to luciferase were still responsive to ρ0 induction as long as the PDRE TTCCACGGAA was present.
“in the case of *CDR1*, we previously analyzed function of the promoter and found that truncation mutant forms of this promoter fused to luciferase were still responsive to ρ0 induction as long as the PDRE TTCCACGGAA was present ([15](#B15))”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [15](#B15)
Not checked in the free run.
- Premisecitation
Other work implicating FLR1 as a target gene for Pdr1/3 in S. cerevisiae lacked demonstration of DNA binding to this promoter.
“Other work implicating *FLR1* as a target gene for Pdr1/3 in *S. cerevisiae* lacked demonstration of DNA binding to this promoter ([29](#B29)).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [29](#B29)
Not checked in the free run.
- Premisecitation
Gain-of-function Pdr1 mutants cause Pdr1 to become hyperactive and stimulate expression of downstream genes that lead to dramatic decreases in azole susceptibility.
“These GOF mutants cause Pdr1 to become hyperactive and stimulate expression of downstream genes that in turn lead to dramatic decreases in azole susceptibility ([7](#B7)).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [7] Tsai HF, Krol AA, Sarti KE, Bennett JE. 2006. Candida glabrata PDR1, a transcriptional regulator of a pleiotropic drug resistance network, mediates azole resistance in clinical isolates and petite mutants. Antimicrob. Agents Chemother. 50:1384–1392. 10.1128/AAC.50.4.1384-1392.2006. [[DOI](https://doi.org/10.1128/AAC.50.4.1384-1392.2006)] [[PMC free article](/articles/PMC1426987/)] [[PubMed](https://pubmed.ncbi.nlm.nih.gov/16569856/)] [[Google Scholar](https://scholar.google.com/scholar_lookup?journal=Antimicrob.%20Agents%20Chemother.&title=Candida%20glabrata%20PDR1,%20a%20transcriptional%20reg source
Not checked in the free run.
- Premisecitation
None of the genes CAGL0B02101/CAGL0B02079 and CAGL0C02937g/CAGL0C02893g were reported to be induced in rho0 cells.
“Since none of these genes were reported to be induced in ρ0 cells ([14](#B14)), the significance of the association with Pdr1 remains to be determined.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [14] Ferrari S, Sanguinetti M, De Bernardis F, Torelli R, Posteraro B, Vandeputte P, Sanglard D. 2011. Loss of mitochondrial functions associated with azole resistance in Candida glabrata results in enhanced virulence in mice. Antimicrob. Agents Chemother. 55:1852–1860. 10.1128/AAC.01271-10. [[DOI](https://doi.org/10.1128/AAC.01271-10)] [[PMC free article](/articles/PMC3088236/)] [[PubMed](https://pubmed.ncbi.nlm.nih.gov/21321146/)] [[Google Scholar](https://scholar.google.com/scholar_lookup?journal=Antimicrob.%20Agents%20Chemother.&title=Loss%20of%20mitochondrial%20functions%20associated%20with%20 source
Not checked in the free run.
- Premisecitation
Loss of the mitochondrial genome leads to constitutive activation of otherwise wild-type Pdr1.
“A second mechanism is provided by loss of the mitochondrial genome, which leads to constitutive activation of otherwise wild-type Pdr1 ([8](#B8)).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [8] Sanglard D, Ischer F, Bille J. 2001. Role of ATP-binding cassette transporter gene in high-frequency acquisition of resistance to azole antifungals in Candida glabrata. Antimicrob. Agents Chemother. 45:1174–1183. 10.1128/AAC.45.4.1174-1183.2001. [[DOI](https://doi.org/10.1128/AAC.45.4.1174-1183.2001)] [[PMC free article](/articles/PMC90441/)] [[PubMed](https://pubmed.ncbi.nlm.nih.gov/11257032/)] [[Google Scholar](https://scholar.google.com/scholar_lookup?journal=Antimicrob.%20Agents%20Chemother.&title=Role%20of%20ATP-binding%20cassette%20transporter%20gene%20in%20high-frequency%20acquisition%2 source
Not checked in the free run.
- Study design and conductown data
Loss of the mitochondrial genome was confirmed by testing representative ethidium bromide-resistant cells for lack of DAPI staining and inability to grow on medium containing a nonfermentable carbon source.
“Loss of the mitochondrial genome was confirmed by testing representative ethidium bromide-resistant cells for lack of DAPI (4′,6-diamidino-2-phenylindole) staining and inability to grown on medium containing a nonfermentable carbon source.”
Quote in the paperSubstantial claim - Interpretationreasoning
Oye2 and Yir036c may represent new acquisitions for the C. glabrata Pdr regulon.
“The remaining enzymes, Oye2 and Yir036c, have not been associated with Pdr regulation in *S. cerevisiae* and may represent new acquisitions for the *C. glabrata* Pdr regulon.”
Quote in the paperNot a substantial claim- Rests on an assumption: Oye2 and Yir036c have not been associated with Pdr regulation in S. cerevisiae.
- Interpretationreasoning
NCE103 might be a contributor to the observed increase in virulence in C. glabrata with activated Pdr1.
“suggesting that *NCE103* might be a contributor to the observed increase in virulence in *C. glabrata* with activated Pdr1.”
Quote in the paperNot a substantial claim - Interpretationreasoning
YIM1 and MEC3 seem likely to be coregulated by Pdr1.
“Both of these loci were induced in ρ0 cells and seem likely to be coregulated by Pdr1.”
Quote in the paperNot a substantial claim - Interpretationown data
These experiments point to the unique aspects of the Pdr regulon of C. glabrata compared to that of S. cerevisiae.
“These experiments point to the unique aspects of the Pdr regulon of *C. glabrata* compared to that of *S. cerevisiae*.”
Quote in the paperSubstantial claim - Premisecitation
The CAGL0A01650g locus was similarly found to be induced in strains containing GOF forms of Pdr1.
“This locus was similarly found to be induced in strains containing GOF forms of Pdr1 ([7](#B7), [10](#B10)[–](#B11)[12](#B12)).”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [7](#B7)
Not checked in the free run.
- cites [10](#B10)
Not checked in the free run.
- cites [12](#B12)
Not checked in the free run.
- May combine two claims. 22
- Classified as probably not a substantial claim. 27
May combine two claims.
Findingown dataA strong ChIP-seq signal was detected at the PDR1 promoter using the anti-TAP antibody, but this was not reproduced with the anti-Pdr1 antiserum.
“While a strong ChIP-seq signal was detected using the anti-TAP antibody, we were not able to reproduce this with the anti-Pdr1 antiserum.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataMEME analysis detected a site closely related to the S. cerevisiae PDRE and very similar to a site identified earlier in C. glabrata based on expression analyses.
“This analysis detected a site ([Fig. 2B](#F2)) closely related to the *S. cerevisiae* PDRE that is also very similar to a site identified earlier in *C. glabrata* based on expression analyses ([11](#B11)).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [11](#B11)
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataThe proteins encoded by the Pdr1-regulated genes fit into roughly 7 different categories.
“The proteins encoded by these genes fit into roughly 7 different categories.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Findingnone givenYIM1 is one of a divergently transcribed gene pair, with the DNA repair enzyme Mec3 encoded by the neighboring gene.
“*YIM1* is one of a divergently transcribed gene pair, with the DNA repair enzyme Mec3 encoded by the neighboring gene.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingnone givenSeveral other Pdr1 target genes are related at some level to metabolic functions but have additional recognized roles.
“Several other Pdr1 target genes are related at some level to metabolic functions but have additional recognized roles.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataA gene encoding a second mitochondrial protein, called Yim1, was also induced in ρ0 cells and contained a likely PDRE in its promoter.
“A gene encoding a second mitochondrial protein, called Yim1, was also induced in ρ0 cells and contained a likely PDRE in its promoter.”
Quote in the paperNot a substantial claimMay combine two claims.
FindingreasoningBoth the YIM1 and MEC3 loci were induced in ρ0 cells.
“Both of these loci were induced in ρ0 cells and seem likely to be coregulated by Pdr1.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataNCE103 is a Pdr1-regulated gene involved in metabolism, encoding a carbonic anhydrase homologue.
“The final Pdr1-regulated gene involved in metabolism is the *NCE103* gene, encoding a carbonic anhydrase homologue.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataCAGL0A01650g encodes a relatively acidic and small protein of 118 residues.
“This gene encodes a relatively acidic and small protein of 118 residues.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingnone givenThe protein produced by the S. cerevisiae YGR346c gene shares no significant similarity with the C. glabrata protein.
“However, the protein produced by this gene shares no significant similarity with the *C. glabrata* protein.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim.
Study design and conductown dataUsing MEME to examine the DNA regions minimized bias in the analysis of C. glabrata promoters.
“In order to minimize bias in our analysis of these *C. glabrata* promoters, we used the software tool MEME ([27](#B27)) to examine all of these DNA regions for common elements.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [27](#B27)
Not checked in the free run.
May combine two claims.
Study design and conductown dataThe recombinant Pdr1 fragment was shown to bind DNA in a sequence-specific manner, indicating it was likely to fold correctly when produced in bacteria.
“This fragment was shown to be able to bind DNA in a sequence-specific manner, indicating that it was likely to fold correctly when produced in bacteria, and was used to raise a polyclonal antiserum from rabbits.”
Quote in the paperSubstantial claimMay combine two claims.
Premiseown dataIn that mutant derivative, the last two PDREs predicted from sequence considerations (TTCCACGGGA and CTCCACGGGA) would still be present, yet no ρ0 activation was seen.
“However, in this mutant derivative, the last two PDREs predicted from sequence considerations (TTCCACGGGA and CTCCACGGGA) would still be present, yet we saw no ρ0 activation.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [15](#B15)
Not checked in the free run.
Classified as probably not a substantial claim.
Study design and conductnone givenWhere replicate samples were found, an irreproducible discovery rate cutoff of 0.01 was used to establish significance threshold criteria.
“Where replicate samples were found, an irreproducible discovery rate cutoff of 0.01 was used to establish significance threshold criteria; otherwise, significance was not determined, but further filtering was done by merging peaks called under different conditions, and the overlap between sets was used.”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationown dataThe TAP-tagged version of Pdr1 retains the normal function and regulation of wild-type Pdr1.
“This comparison was taken as evidence that the TAP-tagged version of Pdr1 retains the normal function and regulation of wild-type Pdr1.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationThe consensus PDRE in S. cerevisiae contains the core element TCCGCGGA and is found in the vast majority of genes under the control of the Pdr regulon.
“The consensus PDRE in *S. cerevisiae* contains the core element TCCGCGGA and is found in the vast majority of genes under the control of the Pdr regulon (reviewed in references [24](#B24) to [26](#B26)).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [24](#B24)
Not checked in the free run.
- cites [26](#B26)
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenStandard single gene ChIP analysis was used to confirm the ChIP-seq data.
“We used standard single gene ChIP analysis to confirm our ChIP-seq data.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
InterpretationcitationATF2 encodes a related enzyme that may also function in detoxification.
“A related enzyme that may also function in detoxification is encoded by *ATF2*.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThese oxidoreductases are thought to contribute to drug resistance via detoxification or repair of macromolecules in the cell.
“These oxidoreductases are thought to contribute to drug resistance via detoxification or repair of macromolecules in the cell ([36](#B36)).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [36](#B36)
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationActivation of the Pdr regulon has been argued to be involved in DNA repair in S. cerevisiae.
“Activation of the Pdr regulon has been argued to be involved in DNA repair in *S. cerevisiae* ([52](#B52)).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [52](#B52)
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
InterpretationreasoningYim1 is also an oxidoreductase and may provide a mitochondrial equivalent of proteins like Ynl034c.
“Yim1 is also an oxidoreductase and may provide a mitochondrial equivalent of proteins like Ynl034c, for example.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationS. cerevisiae has at least 4 other ABCC-class vacuolar ABC transporters, and there is essentially no data linking any of these with multidrug resistance in this organism.
“While *S. cerevisiae* has at least 4 other ABCC-class vacuolar ABC transporters (reviewed in reference [32](#B32)), there is essentially no data linking any of these with multidrug resistance in this organism.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [32](#B32)
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationIpt1 directs synthesis of the final complex sphingolipid present in the plasma membrane, while Pdr16 is involved in lipid droplet mobilization and phosphoinositide signaling.
“Ipt1 directs synthesis of the final complex sphingolipid present in the plasma membrane ([41](#B41)), while Pdr16 is involved in lipid droplet mobilization and phosphoinositide signaling ([42](#B42)).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [41](#B41)
Not checked in the free run.
- cites [42](#B42)
Not checked in the free run.
May combine two claims.
PremisecitationNCE103 plays an essential role in growth in the presence of low CO2 levels; high CO2 levels support growth when NCE103 is deleted from C. glabrata, S. cerevisiae, or C. albicans.
“This enzyme plays an essential role in growth in the presence of low CO2 levels; high CO2 levels support growth when *NCE103* is deleted from *C. glabrata* ([37](#B37)), as well as *S. cerevisiae* ([38](#B38)) or *C. albicans* ([39](#B39)).”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [37](#B37)
Not checked in the free run.
- cites [38](#B38)
Not checked in the free run.
- cites [39](#B39)
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationTwo oxidoreductases, encoded by YMR102c and YNL134c, were found to be regulated by either Yrr1 or Pdr1 in S. cerevisiae and implicated as part of the Pdr regulon in this organism.
“Two of these oxidoreductases, encoded by *YMR102c* and *YNL134c*, were found to be regulated by either Yrr1 or Pdr1 in *S. cerevisiae* and implicated as part of the Pdr regulon in this organism ([34](#B34), [35](#B35)).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [34](#B34)
Not checked in the free run.
- cites [35](#B35)
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationBoth IPT1 and PDR16 were previously shown to be under the control of the Pdr regulon in S. cerevisiae.
“Both of these genes were previously shown to be under the control of the Pdr regulon in *S. cerevisiae* ([43](#B43), [44](#B44)).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [43](#B43)
Not checked in the free run.
- cites [44](#B44)
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationATF2 is outside the S. cerevisiae Pdr regulon and plays an important role in modification of alkyl compounds to ester derivatives.
“This gene is also outside the *S. cerevisiae* Pdr regulon and plays an important role in modification of alkyl compounds to ester derivatives ([37](#B37)).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [37](#B37)
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationBag7 controls the activity of the Rho1 GTPase in S. cerevisiae in a manner distinct from that of its close relative Sac7.
“Bag7 controls the activity of the Rho1 GTPase in *S. cerevisiae* in a manner distinct from that of its close relative Sac7 ([49](#B49)).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [49](#B49)
Not checked in the free run.
May combine two claims.
PremisecitationOverproduction of Pup1 and Cdr1 was sufficient to partially reproduce the phenotypes of clinical isolates containing GOF forms of Pdr1, consistent with the idea that these two genes are major contributors to the downstream effects of Pdr1 genetic activation.
“Overproduction of Pup1 and Cdr1 was sufficient to partially reproduce the phenotypes of clinical isolates containing GOF forms of Pdr1, consistent with the idea that these two genes are major contributors to the downstream effects of Pdr1 genetic activation ([50](#B50)).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [50](#B50)
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThese membrane proteins are overproduced in azole-resistant C. glabrata, C. albicans, and S. cerevisiae.
“These membrane proteins are overproduced in azole-resistant *C. glabrata*, *C. albicans*, and *S. cerevisiae* ([12](#B12), [45](#B45), [46](#B46)).”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [12](#B12)
Not checked in the free run.
- cites [45](#B45)
Not checked in the free run.
- cites [46](#B46)
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationEvidence exists that these 7-TM proteins can control internalization of both membrane proteins and sphingolipid intermediates at the level of the plasma membrane.
“Their precise biological function is somewhat controversial, but evidence exists that these 7-TM proteins can control internalization of both membrane proteins and sphingolipid intermediates at the level of the plasma membrane ([47](#B47), [48](#B48)).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [47](#B47)
Not checked in the free run.
- cites [48](#B48)
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationREV1 encodes a DNA polymerase important in translesion repair.
“which encodes a DNA polymerase important in translesion repair (reviewed in reference [51](#B51))”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [51](#B51)
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationPUP1 was previously identified as a strong and commonly induced gene in clinical isolates, although its function is unknown.
“*PUP1* was previously identified as a strong and commonly induced gene in clinical isolates ([50](#B50)), although its function is unknown.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [50](#B50)
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationYbt1 is localized to the vacuolar membrane-localized ABCC ABC transporter that has been implicated in phosphatidylcholine metabolism in S. cerevisiae.
“Ybt1 is localized to the vacuolar membrane-localized ABCC ABC transporter that has been implicated in phosphatidylcholine metabolism in *S. cerevisiae* ([30](#B30), [31](#B31)).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [30](#B30)
Not checked in the free run.
- cites [31](#B31)
Not checked in the free run.
Classified as probably not a substantial claim.
PremisecitationCO2 sensing regulates virulence in C. albicans and Cryptococcus neoformans.
“CO2 sensing regulates virulence in *C. albicans* ([39](#B39)) and *Cryptococcus neoformans* ([40](#B40))”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [39](#B39)
Not checked in the free run.
- cites [40](#B40)
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationAn ABCC transporter required for normal virulence is found in the vacuole of the major fungal pathogen Candida albicans.
“Strikingly, an ABCC transporter required for normal virulence is found in the vacuole of the major fungal pathogen *Candida albicans* ([33](#B33)).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [33](#B33)
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationHAP1 encodes a zinc finger-containing transcription factor that can function as an activator protein under aerobic conditions and a repressor in the absence of oxygen.
“*HAP1* encodes a zinc finger-containing transcription factor that can function as an activator protein under aerobic conditions and a repressor in the absence of oxygen ([54](#B54)).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [54](#B54)
Not checked in the free run.
May combine two claims.
Interpretationown dataC. glabrata Pdr1 binds upstream of and regulates novel genes that show no evidence for coordinate transcriptional control in S. cerevisiae.
“While in broad strokes (increased expression of ABC transporters, membrane biosynthetic enzymes, and metabolic enzymes) these responses are similar, *C. glabrata* Pdr1 binds upstream of and regulates novel genes that show no evidence for coordinate transcriptional control in *S. cerevisiae*.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationCAGL0A01650g is 12-fold induced in ρ0 cells, making it one of the top 5 genes responding to this regulatory signal.
“This gene, called *CAGL0A01650g*, is 12-fold induced in ρ0 cells, making it one of the top 5 genes responding to this regulatory signal ([14](#B14)).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [14](#B14)
Not checked in the free run.
May combine two claims.
InterpretationreasoningThese transcription factors can amplify the range of genes that are regulated by Pdr1 and may help explain the larger list of genes exhibiting stimulated expression in strains containing GOF alleles of PDR1.
“These transcription factors can amplify the range of genes that are regulated by Pdr1 and may help explain the larger list of genes exhibiting stimulated expression in strains containing GOF alleles of *PDR1* ([7](#B7), [10](#B10)[–](#B11)[12](#B12)).”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [7](#B7)
Not checked in the free run.
- cites [10](#B10)
Not checked in the free run.
- cites [12](#B12)
Not checked in the free run.
The paper relies on this without support.
Existing transcriptome analyses cannot separate direct from indirect Pdr1 target genes.
“While extensive analyses of the transcriptional effects of Pdr1 have identified a number of genes that are regulated by this factor, we cannot yet separate direct from indirect target genes.”
“While the picture of the Pdr1-responsive transcriptome is well developed, we know very little about the direct targets of this transcription factor.”
The paper relies on this without support.
The anti-Pdr1 antiserum specifically immunoprecipitates Pdr1 in the ChIP assays.
“In all cases, the anti-Pdr1 antiserum was used as the immunoprecipitating antibody.”
The paper relies on this without support.
Oye2 and Yir036c have not been associated with Pdr regulation in S. cerevisiae.
“The remaining enzymes, Oye2 and Yir036c, have not been associated with Pdr regulation in *S. cerevisiae* and may represent new acquisitions for the *C. glabrata* Pdr regulon.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Pdr1 DNA-binding is strongly upregulated in ρ0 cells, likely due in part to the large increase in PDR1 expression in this background compared to wild-type cells.
“Pdr1 DNA-binding was strongly upregulated in ρ0 cells, likely due in part to the large increase in PDR1 expression in this background compared to wild-type cells [31].”
From The Candida glabrata Upc2A transcription factor is a global regulator of antifungal drug resistance pathways (2021) · cites this paper as [31]
Cites
Robinson, J. T., Thorvaldsdóttir, H., Winckler, W., Guttman, M., Lander, E. S., Getz, G., & Mesirov, J. P. (2011) · Nature Biotechnology · doi:10.1038/nbt.1754 · Cited by 15,390 · see citing works
Heinz, S., Benner, C., Spann, N., Bertolino, E., Lin, Y. C., Laslo, P., Cheng, J. X., Murre, C., Singh, H., & Glass, C. K. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.05.004 · Cited by 13,382 · see citing works
MEME SUITE: tools for motif discovery and searching
Bailey, T. L., Boden, M., Buske, F. A., Frith, M., Grant, C. E., Clementi, L., Ren, J., Li, W. W., & Noble, W. S. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkp335 · Cited by 10,648 · see citing works
Sherman, F., Fink, G. R., & Hicks, J. B. (1979) · Cold Spring Harbor Laboratory eBooks · Cited by 7,543 · see citing works
Hidden Killers: Human Fungal Infections
Brown, G. D., Denning, D. W., Gow, N. A. R., Levitz, S. M., Netea, M. G., & White, T. C. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3004404 · Cited by 4,284 · see citing works
ChIPpeakAnno: a Bioconductor package to annotate ChIP-seq and ChIP-chip data
Zhu, L., Gazin, C., Lawson, N., Pagès, H., Lin, S. M., Lapointe, D. S., & Green, M. R. (2010) · BMC Bioinformatics · doi:10.1186/1471-2105-11-237 · Cited by 1,144 · see citing works
EUKARYOTIC TRANSLESION SYNTHESIS DNA POLYMERASES: Specificity of Structure and Function
Prakash, S., Johnson, R. E., & Prakash, L. (2005) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.74.082803.133250 · Cited by 999 · see citing works
Silva, S., Negri, M., Henriques, M., Oliveira, R., Williams, D. W., & Azeredo, J. (2012) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2011.00278.x · Cited by 969 · see citing works
A Fungal Family of Transcriptional Regulators: the Zinc Cluster Proteins
MacPherson, S., Larochelle, M., & Turcotte, B. (2006) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00015-06 · Cited by 612 · see citing works
Antifungal Drug Development: Challenges, Unmet Clinical Needs, and New Approaches
Roemer, T., & Krysan, D. J. (2014) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a019703 · Cited by 593 · see citing works
Xie, Y., & Varshavsky, A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.071022298 · Cited by 436 · see citing works
Genetic reconstruction of a functional transcriptional regulatory network
Hu, Z., Killion, P. J., & Iyer, V. R. (2007) · Nature Genetics · doi:10.1038/ng2012 · Cited by 415 · see citing works
Pfaller, M. A., Andes, D. R., Diekema, D. J., Horn, D. L., Reboli, A. C., Rotstein, C., Franks, B., & Azie, N. E. (2014) · PLoS ONE · doi:10.1371/journal.pone.0101510 · Cited by 396 · see citing works
Verstrepen, K. J., Laere, S. D. M. V., Vanderhaegen, B., Derdelinckx, G., Dufour, J., Pretorius, I. S., Winderickx, J., Thevelein, J. M., & Delvaux, F. R. (2003) · Applied and Environmental Microbiology · doi:10.1128/aem.69.9.5228-5237.2003 · Cited by 394 · see citing works
Sanglard, D., Ischer, F., Calabrese, D., Majcherczyk, P. A., & Bille, J. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.11.2753 · Cited by 337 · see citing works
Ferrari, S., Ischer, F., Calabrese, D., Posteraro, B., Sanguinetti, M., Fadda, G., Rohde, B., Bauser, C., Bader, O., & Sanglard, D. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000268 · Cited by 295 · see citing works
Vermitsky, J.-P., & Edlind, T. D. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.10.3773-3781.2004 · Cited by 285 · see citing works
BAUER, B. E., Wolfger, H., & Kuchler, K. (1999) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(99)00160-1 · Cited by 278 · see citing works
Genome microarray analysis of transcriptional activation in multidrug resistance yeast mutants
DeRisi, J. L., van den Hazel, B., Marc, P., Balzi, E., Brown, P. O., Jacq, C., & Goffeau, A. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01294-1 · Cited by 276 · see citing works
Sanglard, D., Ischer, F., & Bille, J. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.4.1174-1183.2001 · Cited by 247 · see citing works
Tsai, H.-F., Krol, A. A., Sarti, K. E., & Bennett, J. E. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.4.1384-1392.2006 · Cited by 237 · see citing works
Vermitsky, J., Earhart, K. D., Smith, W. L., Homayouni, R., Edlind, T. D., & Rogers, P. D. (2006) · Molecular Microbiology · doi:10.1111/j.1365-2958.2006.05235.x · Cited by 233 · see citing works
Transcriptional control of the yeast PDR5 gene by the PDR3 gene product.
Katzmann, D. J., Burnett, P. E., Golin, J. E., Mahé, Y., & Moye-Rowley, S. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.7.4653 · Cited by 216 · see citing works
Traven, A., Wong, J. M. S., Xu, D., Sopta, M., & Ingles, C. J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m006807200 · Cited by 213 · see citing works
Bahn, Y.-S., Cox, G. M., Perfect, J. R., & Heitman, J. (2005) · Current Biology · doi:10.1016/j.cub.2005.09.047 · Cited by 205 · see citing works
Paumi, C. M., Chuk, M., Snider, J. D., Štagljar, I., & Michaelis, S. (2009) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00020-09 · Cited by 189 · see citing works
Dickson, R. C., Nagiec, E. E., Wells, G. B., Nagiec, M. M., & Lester, R. L. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.47.29620 · Cited by 181 · see citing works
van den Hazel, H. B., Pichler, H., Matta, M. A. D. V., Leitner, E., Goffeau, A., & Daum, G. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.4.1934 · Cited by 157 · see citing works
Ferrari, S., Sanguinetti, M., De Bernardis, F., Torelli, R., Posteraro, B., Vandeputte, P., & Sanglard, D. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01271-10 · Cited by 144 · cited 5× · see citing works
“glabrata strains containing activated Pdr1 also exhibit increased virulence in murine models of infection have been obtained (13, 14).”
BackgroundInfluentialMultidrug resistance in fungi: regulation of transporter-encoding gene expression
Paul, S., & Moye-Rowley, W. S. (2014) · Frontiers in Physiology · doi:10.3389/fphys.2014.00143 · Cited by 137 · see citing works
Self-citationHickman, M. J., & Winston, F. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00887-07 · Cited by 137 · see citing works
Kihara, A., & Igarashi, Y. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203385200 · Cited by 113 · see citing works
Contribution of CgPDR1-Regulated Genes in Enhanced Virulence of Azole-Resistant Candida glabrata
Ferrari, S., Sanguinetti, M., Torelli, R., Posteraro, B., & Sanglard, D. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017589 · Cited by 110 · see citing works
Diversity, taxonomy and evolution of medium‐chain dehydrogenase/reductase superfamily
Riveros‐Rosas, H., Julián‐Sánchez, A., Villalobos‐Molina, R., Pardo, J. P., & Piña, E. (2003) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2003.03704.x · Cited by 103 · see citing works
Katzmann, D. J., Epping, E. A., & Moye-Rowley, S. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.4.2998 · Cited by 97 · see citing works
Rogers, P. D., & Barker, K. S. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.11.3412-3417.2002 · Cited by 96 · see citing works
Genomewide Expression Profile Analysis of the Candida glabrata Pdr1 Regulon
Caudle, K. E., Barker, K. S., Wiederhold, N. P., Xu, L., Homayouni, R., & Rogers, P. D. (2010) · Eukaryotic Cell · doi:10.1128/ec.00073-10 · Cited by 92 · see citing works
Knutson, B. A., & Hahn, S. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.00687-10 · Cited by 89 · see citing works
Aguilera, J., van Dijken, J. P., de Winde, J. H., & Pronk, J. T. (2005) · Biochemical Journal · doi:10.1042/bj20050556 · Cited by 88 · see citing works
A Yeast ATP-binding Cassette-type Protein Mediating ATP-dependent Bile Acid Transport
Ortiz, D. F., St.-Pierre, M. V., Abdulmessih, A., & Arias, I. M. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.24.15358 · Cited by 87 · see citing works
Genome‐wide studies on the nuclear PDR3‐controlled response to mitochondrial dysfunction in yeast
Devaux, F., Carvajal, E., Moye-Rowley, S., & Jacq, C. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)02387-6 · Cited by 85 · see citing works
Coordinate Control of Sphingolipid Biosynthesis and Multidrug Resistance in Saccharomyces cerevisiae
Hallstrom, T. C., Lambert, L., Schorling, S., Balzi, E., Goffeau, A., & Moye-Rowley, S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101568200 · Cited by 82 · see citing works
Tsai, H.-F., Sammons, L. R., Zhang, X., Suffis, S. D., Su, Q., Myers, T. G., Marr, K. A., & Bennett, J. E. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00535-10 · Cited by 80 · see citing works
Transformation of Candida albicans by electroporation
Backer, M. D. D., Maes, D., Vandoninck, S., Logghe, M., Contreras, R., & Luyten, W. H. M. L. (1999) · Yeast · doi:10.1002/(sici)1097-0061(199911)15:15 · Cited by 80 · see citing works
Genes conserved in yeast and humans
Tugendreich, S., Bassett, D. E., McKusick, V. A., Boguski, M., & Hieter, P. (1994) · Human Molecular Genetics · doi:10.1093/hmg/3.suppl_1.1509 · Cited by 78 · see citing works
Regulation of the CgPdr1 Transcription Factor from the Pathogen Candida glabrata
Paul, S., Schmidt, J. A., & Moye-Rowley, W. S. (2011) · Eukaryotic Cell · doi:10.1128/ec.00277-10 · Cited by 78 · see citing works
Self-citationRen, J., Lin, C. P. C., Pathak, M. C., Temple, B. R. S., Nile, A. H., Mousley, C. J., Duncan, M. C., Eckert, D. M., Leiker, T. J., Ivanova, P. T., et al. (2014) · Molecular Biology of the Cell · doi:10.1091/mbc.e13-11-0634 · Cited by 77 · see citing works
Costa, C., Pires, C. M. B. F., Cabrito, T. R., Renaudin, A., Ohno, M., Chibana, H., Sá‐Correia, I., & Teixeira, M. C. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00811-12 · Cited by 65 · see citing works
Lucau‐Danila, A., Delaveau, T., Lelandais, G., Devaux, F., & Jacq, C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m309580200 · Cited by 59 · see citing works
The RHO1‐GAPs SAC7, BEM2 and BAG7 control distinct RHO1 functions in Saccharomyces cerevisiae
Schmidt, A., Schmelzle, T., & Hall, M. N. (2002) · Molecular Microbiology · doi:10.1046/j.1365-2958.2002.03110.x · Cited by 57 · see citing works
Theiß, S., Kretschmar, M., Nichterlein, T., Hof, H., Agabian, N. M., Hacker, J. H., & Köhler, G. A. (2002) · Molecular Microbiology · doi:10.1046/j.1365-2958.2002.02769.x · Cited by 55 · see citing works
The bZIP Transcription Factor Rca1p Is a Central Regulator of a Novel CO2 Sensing Pathway in Yeast
Cottier, F., Raymond, M., Kurzai, O., Bolstad, M., Leewattanapasuk, W., Jiménez-López, C., Lorenz, M. C., Sanglard, D., Váchová, L., Pavelka, N., et al. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002485 · Cited by 55 · see citing works
Transcriptional Control of the Yeast PDR5 Gene by the PDR3 Gene Product
Katzmann, D. J., Burnett, P. E., Golin, J. E., Mahé, Y., & Moye-Rowley, S. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.7.4653-4661.1994 · Cited by 51 · see citing works
Vacuolar Import of Phosphatidylcholine Requires the ATP‐Binding Cassette Transporter Ybt1
Gulshan, K., & Moye-Rowley, S. (2011) · Traffic · doi:10.1111/j.1600-0854.2011.01228.x · Cited by 36 · see citing works
Johnson, S. S., Hanson, P. K., Manoharlal, R., Brice, S. E., Cowart, L. A., & Moye-Rowley, S. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.162883 · Cited by 33 · see citing works
Pdr3 is required for DNA damage induction of MAG1 and DDI1 via a bi-directional promoter element
Zhu, Y. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkh838 · Cited by 31 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Azole Antifungal Resistance in Candida albicans and Emerging Non-albicans Candida Species
Whaley, S. G., Berkow, E. L., Rybak, J. M., Nishimoto, A. T., Barker, K. S., & Rogers, P. D. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.02173 · Cited by 900 · see citing works
Antifungal Drug Resistance: Molecular Mechanisms in <i>Candida albicans</i> and Beyond
Lee, Y., Puumala, E., Robbins, N., & Cowen, L. E. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.0c00199 · Cited by 801 · see citing works
AtrR Is an Essential Determinant of Azole Resistance in Aspergillus fumigatus
Paul, S., Stamnes, M., Thomas, G. H., Liu, H., Hagiwara, D., Gomi, K., Filler, S. G., & Moye-Rowley, W. S. (2019) · mBio · doi:10.1128/mbio.02563-18 · Cited by 91 · see citing works
Self-citationAzole Resistance in Candida glabrata
Whaley, S. G., & Rogers, P. D. (2016) · Current Infectious Disease Reports · doi:10.1007/s11908-016-0554-5 · Cited by 85 · see citing works
Drug resistance mechanisms and their regulation in non- albicans Candida species
Kołaczkowska, A., & Kołaczkowski, M. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv445 · Cited by 88 · see citing works
Verma, S., Shakya, V. P. S., & Idnurm, A. (2018) · Virulence · doi:10.1080/21505594.2017.1414133 · Cited by 67 · see citing works
Tipping the balance both ways: drug resistance and virulence in Candida glabrata
Vale-Silva, L. A., & Sanglard, D. (2015) · FEMS Yeast Research · doi:10.1093/femsyr/fov025 · Cited by 68 · see citing works
Vu, B. G., Thomas, G. H., & Moye-Rowley, W. S. (2019) · mBio · doi:10.1128/mbio.00934-19 · Cited by 59 · see citing works
Whaley, S. G., Zhang, Q., Caudle, K. E., & Rogers, P. D. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01070-18 · Cited by 59 · see citing works
Gale, A. N., Sakhawala, R. M., Levitan, A., Sharan, R., Berman, J., Timp, W., & Cunningham, K. W. (2020) · G3 Genes|Genomes|Genetics · doi:10.1534/g3.120.401595 · Cited by 56 · see citing works
Vale-Silva, L. A., Moeckli, B., Torelli, R., Posteraro, B., Sanguinetti, M., & Sanglard, D. (2016) · mSphere · doi:10.1128/msphere.00065-15 · Cited by 51 · see citing works
Šimoničová, L., & Moye-Rowley, S. (2020) · PLoS Genetics · doi:10.1371/journal.pgen.1009005 · Cited by 41 · see citing works
Mechanisms of azole resistance among clinical isolates of Candida glabrata in Poland
Szweda, P., Gucwa, K., Romanowska, E., Dzierżanowska‐Fangrat, K., Naumiuk, Ł., Brillowska‐Dąbrowska, A., Wojciechowska‐Koszko, I., & Milewski, S. (2015) · Journal of Medical Microbiology · doi:10.1099/jmm.0.000062 · Cited by 42 · see citing works
Vu, B. G., Stamnes, M. A., Li, Y., Rogers, P. D., & Moye-Rowley, W. S. (2021) · PLOS Genetics · doi:10.1371/journal.pgen.1009582 · Cited by 39 · see citing works
A network of paralogous stress response transcription factors in the human pathogen Candida glabrata
Merhej, J., Thiebaut, A., Blugeon, C., Pouch, J., Ali Chaouche, M. E. A., Camadro, J.-M., Le Crom, S., Lelandais, G., & Devaux, F. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.00645 · Cited by 36 · see citing works
Moye-Rowley, S. (2018) · Current Genetics · doi:10.1007/s00294-018-0870-4 · Cited by 29 · see citing works
Khakhina, S., Šimoničová, L., & Moye-Rowley, S. (2018) · Molecular Microbiology · doi:10.1111/mmi.13913 · Cited by 27 · see citing works
Pais, P., Pires, C. M. B. F., Costa, C., Okamoto, M., Chibana, H., & Teixeira, M. C. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.02045 · Cited by 29 · see citing works
Gale, A. N., Pavesic, M. W., Nickels, T. J., Xu, Z., Cormack, B. P., & Cunningham, K. W. (2023) · mSphere · doi:10.1128/msphere.00254-23 · Cited by 27 · see citing works
Jjj1 Is a Negative Regulator of Pdr1-Mediated Fluconazole Resistance in Candida glabrata
Whaley, S., Caudle, K. E., Šimoničová, L., Zhang, Q., Moye-Rowley, S., & Rogers, P. D. (2018) · mSphere · doi:10.1128/msphere.00466-17 · Cited by 21 · see citing works
Ollinger, T. L., Vu, B. G., Murante, D., Parker, J. E., Šimoničová, L., Doorley, L. A., Stamnes, M. A., Kelly, S. L., Rogers, P. D., Moye-Rowley, S., et al. (2021) · mSphere · doi:10.1128/msphere.00830-21 · Cited by 14 · see citing works
Culakova, H., Dzugasova, V., Valencikova, R., Gbelska, Y., & Subik, J. (2015) · Microbiological Research · doi:10.1016/j.micres.2015.03.004 · Cited by 11 · see citing works
Naskar, S., Prajapati, A., & Kaur, R. (2025) · FEMS Yeast Research · doi:10.1093/femsyr/foaf025 · Cited by 11 · see citing works
The hidden threat: Unveiling the rise of antifungal drug resistance
Chaudhary, R., & Thakur, Z. (2025) · Microbial Pathogenesis · doi:10.1016/j.micpath.2025.108068 · Cited by 12 · see citing works
Calcineurin is required for Candida glabrata Pdr1 transcriptional activation
Vu, B. G., Šimoničová, L., & Moye-Rowley, S. (2023) · mBio · doi:10.1128/mbio.02416-23 · Cited by 10 · see citing works
Paul, S. K., McDonald, W. H., & Moye-Rowley, S. (2018) · Molecular Microbiology · doi:10.1111/mmi.14109 · Cited by 11 · see citing works
Self-citationNickels, T. J., Gale, A. N., Harrington, A. A., Timp, W., & Cunningham, K. W. (2024) · G3 Genes Genomes Genetics · doi:10.1093/g3journal/jkae173 · Cited by 10 · see citing works
Navarro-Rodríguez, P., Martín‐Vicente, A., López‐Fernández, L., Guarro, J., & Capilla, J. (2019) · Medical Mycology · doi:10.1093/mmy/myz014 · Cited by 9 · see citing works
Nickels, T. J., & Cunningham, K. W. (2025) · mSphere · doi:10.1128/msphere.00270-25 · Cited by 8 · see citing works
Screening the Drug:H+ Antiporter Family for a Role in Biofilm Formation in Candida glabrata
Santos, R., Cavalheiro, M., Costa, C., Takahashi‐Nakaguchi, A., Okamoto, M., Chibana, H., & Teixeira, M. C. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.00029 · Cited by 8 · see citing works
Tian, Y., Zhuang, Y., Chen, Z., Mao, Y., Zhang, J., Lu, R., & Guo, L. (2020) · Microbiological Research · doi:10.1016/j.micres.2020.126519 · Cited by 7 · see citing works
Paul, S. K., Stamnes, M. A., & Moye-Rowley, S. (2023) · G3 Genes Genomes Genetics · doi:10.1093/g3journal/jkad173 · Cited by 7 · see citing works
Self-citationCharacterization of the Candida glabrata Transcription Factor CgMar1: Role in Azole Susceptibility
Pais, P., Galocha, M., Califórnia, R., Viana, R., Ola, M., Okamoto, M., Chibana, H., Butler, G., & Teixeira, M. C. (2022) · Journal of Fungi · doi:10.3390/jof8010061 · Cited by 7 · see citing works
Tian, Y., Gao, N., Ni, Q., Mao, Y., Dong, D., Huang, X., Jiang, C., Li, Z., Zhang, L., Wang, X., et al. (2018) · FEMS Yeast Research · doi:10.1093/femsyr/foy038 · Cited by 6 · see citing works
Tantivitayakul, P., Lapirattanakul, J., Kaypetch, R., & Muadcheingka, T. (2019) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2019.01.006 · Cited by 6 · see citing works
Vu, B. G., Stamnes, M. A., Li, Y., Rogers, P. D., & Moye-Rowley, S. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.05.07.443069 · Cited by 4 · see citing works
Zaeske, A. M., Harrington, A. A., Nickels, T. J., Gale, A. N., Timp, W., Alayo, N., Hassoun, Y., Perlin, D. S., Shor, E., & Cunningham, K. W. (2026) · Microbiology Spectrum · doi:10.1128/spectrum.00848-26 · Cited by 2 · see citing works
Šimoničová, L., & Moye-Rowley, S. (2023) · Methods in molecular biology · doi:10.1007/978-1-0716-3155-3_11 · Cited by 2 · see citing works
Jonani, B. (2025) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2025.108201 · Cited by 1 · see citing works
Conway, T. P., Šimoničová, L., & Moye-Rowley, S. (2024) · Genetics · doi:10.1093/genetics/iyae115 · Cited by 1 · see citing works
Ollinger, T. L., Vu, B. G., Murante, D., Parker, J. E., Šimoničová, L., Doorley, L. A., Stamnes, M. A., Kelly, S. L., Rogers, P. D., Moye-Rowley, S., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.10.07.463606 · Cited by 1 · see citing works
Nickels, T. J., Gale, A. N., Harrington, A. A., Timp, W., & Cunningham, K. W. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.05.02.592251 · Cited by 1 · see citing works
Paul, S. K., Stamnes, M. A., & Moye-Rowley, S. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.06.06.543935
Self-citationTranscriptional networks of the stress responses in the human pathogen Candida glabrata
Thiébaut, A. (2018) · theses.fr (ABES) · doi:10.70675/323c74a8z1ae4z4123za081zd0af3ecf65ae
Yin, J., Yang, S., Xiong, K., Gong, S., & Su, C. (2026) · Microbiology Spectrum · doi:10.1128/spectrum.01865-26
- Authors
- Paul, S., Bair, T. B., & Moye-Rowley, W. S.
- Affiliations
- University of Iowa (US)
- Department of Molecular Physiology and Biophysics, Carver College of Medicine, University of Iowa, Iowa City, Iowa USA
- ORCID
- Paul, Sanjoy
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2014-11
- Volume
- 58
- Issue
- 11
- Pages
- 6904-6912
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- PMC
- PMC4249425
- OpenAlex
- W2168210645
- Semantic Scholar
- 8f5c8a797d6ca2b348c208ac5d26bd7ab186a258
- Cited by
- 45
- References
- 56
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 3 · 2023: 5 · 2022: 1 · 2021: 4 · 2020: 5 · 2019: 4 · 2018: 7 · 2017: 2 · 2016: 5 · 2015: 3
- FWCI
- 2.33
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Antimicrobial Agents and Chemotherapy (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Institute of General Medical Sciences (R01GM049825, GM49825)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Yeasts and Rust Fungi Studies
- Keywords
- Candida glabrata, azole resistance, DNA repair genes, transcriptional regulation, promoter identification, ChIP-seq
- MeSH terms
- Antifungal Agents, Base Sequence, Binding Sites, Candidiasis, DNA-Binding Proteins, Fungal Proteins, Mitochondria, Transcription Factors, Fluconazole, Sequence Analysis, DNA, ATP-Binding Cassette Transporters, Drug Resistance, Fungal, Candida glabrata, High-Throughput Nucleotide Sequencing
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-09.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-09.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review